| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 9,542 | 8,453 | 9,098 | 11,787 |
| Investments | 2,260 | 2,145 | 2,134 | 2,386 |
| Accounts receivable, net | 40,992 | 39,779 | 43,857 | 40,651 |
| Inventories | 17,770 | 19,246 | 18,962 | 17,447 |
| Other current assets | 4,253 | 5,091 | 3,058 | 3,378 |
| Total current assets | 74,817 | 74,714 | 77,109 | 75,649 |
| Long-term investments | 32,407 | 32,669 | 31,553 | 29,858 |
| Property and equipment, net | 13,037 | 13,083 | 12,838 | 12,825 |
| Operating lease right-of-use assets | 14,741 | 14,973 | 15,271 | 15,512 |
| Goodwill | 85,478 | 85,478 | 85,478 | 91,203 |
| Intangible assets, net | 25,070 | 25,508 | 25,984 | 26,224 |
| Separate accounts assets | NaN | 1,994 | 1,934 | 1,858 |
| Other assets | 7,424 | 5,119 | 5,160 | 5,214 |
| Total assets | 252,974 | 253,538 | 255,327 | 258,343 |
| Accounts payable | 16,922 | 17,641 | 17,764 | 17,258 |
| Pharmacy claims and discounts payable | 26,149 | 26,344 | 27,085 | 26,338 |
| Health care costs payable | 15,518 | 15,399 | 16,098 | 15,271 |
| Accrued expenses and other current liabilities | 22,258 | 22,387 | 23,415 | 23,101 |
| Other insurance liabilities | 1,075 | 1,116 | 1,096 | 1,088 |
| Current portion of operating lease liabilities | 1,904 | 1,737 | 1,909 | 1,906 |
| Short-term debt | NaN | 0 | 1,247 | 3,040 |
| Current portion of long-term debt | 2,580 | 4,068 | 4,081 | 6,160 |
| Total current liabilities | 86,406 | 88,692 | 92,695 | 94,162 |
| Long-term operating lease liabilities | 13,330 | 13,643 | 14,007 | 14,328 |
| Long-term debt | 60,531 | 60,502 | 60,508 | 57,290 |
| Deferred income taxes | 3,771 | 3,832 | 3,547 | 3,603 |
| Separate accounts liabilities | NaN | 1,994 | 1,934 | 1,858 |
| Other long-term insurance liabilities | 4,592 | 4,716 | 4,767 | 4,769 |
| Other long-term liabilities | 6,707 | 4,777 | 4,759 | 4,782 |
| Total liabilities | 175,337 | 178,156 | 182,217 | 180,792 |
| Common stock, par value 0.01 3,200 shares authorized 1,788 shares issued and 1,273 shares outstanding as of march31, 2026 and 1,787 shares issued and 1,271 shares outstanding as of december31, 2025 and capital surplus | 50,679 | 50,402 | 50,181 | 50,020 |
| Treasury stock, at cost 515 and 516 shares as of march31, 2026 and december31, 2025 | 36,706 | 36,790 | 36,776 | 36,849 |
| Retained earnings | 63,282 | 61,196 | 59,107 | 63,936 |
| Accumulated other comprehensive income | 201 | 406 | 416 | 272 |
| Total cvs health shareholders equity | 77,456 | 75,214 | 72,928 | 77,379 |
| Noncontrolling interests | 181 | 168 | 182 | 172 |
| Total shareholders equity | 77,637 | 75,382 | 73,110 | 77,551 |
| Total liabilities and shareholders equity | 252,974 | 253,538 | 255,327 | 258,343 |
CVS HEALTH Corp (CVS)
CVS HEALTH Corp (CVS)